{"id":{"repo_id":"mcmaster","oai_identifier":"oai:macsphere.mcmaster.ca:11375/10718"},"canonical_url":"https://search.ndltd.org/etd/mcmaster/oai:macsphere.mcmaster.ca:11375/10718","repository":{"repo_id":"mcmaster","name":"McMaster University","base_url":"https://macsphere.mcmaster.ca/server/oai/request"},"display":{"title":"Characterization of Fosfomycin-Resistant MurA from Borrelia burgdorferi, Fragment-based Inhibitor Design for AroA and DAHP Synthase","abstract":"<p>MurA catalyzes the first committed step of peptidoglycan biosynthesis and it is the target of the antibiotic fosfomycin. Due to a Cys-to-Asp substitution in the active site, MurAs from a number of pathogenic bacteria, including <em>Mycobacterium tuberculosis</em> and <em>Borrelia burgdorferi</em> (Lyme disease), are fosfomycin resistant. His-tagged <em>Borrelia burgdorferi</em> MurA (Bb_MurA) and its D116C mutant have been successfully expressed, purified and characterized. The <em>k</em><sub>cat</sub> value of wild-type Bb_MurA was 0.74 ± 0.01 s<sup>-1</sup>. The D116C mutant’s <em>k</em><sub>cat</sub> decreased by 25-fold and was fosfomycin sensitive. The pH profiles of <em>k</em><sub>cat</sub> for both Bb_MurA and its mutant were characterized. There was little difference in p<em>K</em><sub>a1</sub> values, but the p<em>K</em><sub>a2</sub> value shifted from 7.4 ± 0.2 in wild-type enzyme to a value >11 in the mutant. This demonstrated that the p<em>K</em><sub>a2</sub> of 7.4 was due to D116, and that it must be protonated for activity. Fosfomycin inactivation of Bb_MurA<sub>H6</sub>(D116C) was time-dependent and only proceeded in the presence of UDP-GlcNAc. The dissociation constant, <em>K</em><sub>i</sub>, was 5.7 ± 0.4 µM and rate of covalent modification, <em>k</em><sub>inact</sub>, was 0.021 ± 0.003 s<sup>-1</sup>.</p> <p>DAHP synthase catalyzes the first committed step in the shikimate pathway, and its catalysis has been proposed to proceed through two oxacarbenium ion intermediates. Pyruvate oxime, glyoxylate oxime and 4-imidazolecarboxylic acid have been evaluated as inhibitors of DAHP synthase. In the presence of glycerol 3-phosphate, the fitted <em>K</em><sub>i</sub> values of pyruvate oxime and glyoxylate oxime were 7.6 (± 0.9) × 10<sup>-5</sup> M and 7.4 (± 1.7) × 10<sup>-5</sup> M, respectively. 4-Imidazolecarboxylic acid’s inhibition was cooperative, and its binding was competitive with respect to PEP, and uncompetitive with respect to E4P. Its equilibrium dissociation constant was 3.0 (± 0.2) × 10<sup>-3</sup> M.</p>","abstract_html":"&lt;p&gt;MurA catalyzes the first committed step of peptidoglycan biosynthesis and it is the target of the antibiotic fosfomycin. Due to a Cys-to-Asp substitution in the active site, MurAs from a number of pathogenic bacteria, including &lt;em&gt;Mycobacterium tuberculosis&lt;/em&gt; and &lt;em&gt;Borrelia burgdorferi&lt;/em&gt; (Lyme disease), are fosfomycin resistant. His-tagged &lt;em&gt;Borrelia burgdorferi&lt;/em&gt; MurA (Bb_MurA) and its D116C mutant have been successfully expressed, purified and characterized. The &lt;em&gt;k&lt;/em&gt;&lt;sub&gt;cat&lt;/sub&gt; value of wild-type Bb_MurA was 0.74 ± 0.01 s&lt;sup&gt;-1&lt;/sup&gt;. The D116C mutant’s &lt;em&gt;k&lt;/em&gt;&lt;sub&gt;cat&lt;/sub&gt; decreased by 25-fold and was fosfomycin sensitive. The pH profiles of &lt;em&gt;k&lt;/em&gt;&lt;sub&gt;cat&lt;/sub&gt; for both Bb_MurA and its mutant were characterized. There was little difference in p&lt;em&gt;K&lt;/em&gt;&lt;sub&gt;a1&lt;/sub&gt; values, but the p&lt;em&gt;K&lt;/em&gt;&lt;sub&gt;a2&lt;/sub&gt; value shifted from 7.4 ± 0.2 in wild-type enzyme to a value &gt;11 in the mutant. This demonstrated that the p&lt;em&gt;K&lt;/em&gt;&lt;sub&gt;a2&lt;/sub&gt; of 7.4 was due to D116, and that it must be protonated for activity. Fosfomycin inactivation of Bb_MurA&lt;sub&gt;H6&lt;/sub&gt;(D116C) was time-dependent and only proceeded in the presence of UDP-GlcNAc. The dissociation constant, &lt;em&gt;K&lt;/em&gt;&lt;sub&gt;i&lt;/sub&gt;, was 5.7 ± 0.4 µM and rate of covalent modification, &lt;em&gt;k&lt;/em&gt;&lt;sub&gt;inact&lt;/sub&gt;, was 0.021 ± 0.003 s&lt;sup&gt;-1&lt;/sup&gt;.&lt;/p&gt; &lt;p&gt;DAHP synthase catalyzes the first committed step in the shikimate pathway, and its catalysis has been proposed to proceed through two oxacarbenium ion intermediates. Pyruvate oxime, glyoxylate oxime and 4-imidazolecarboxylic acid have been evaluated as inhibitors of DAHP synthase. In the presence of glycerol 3-phosphate, the fitted &lt;em&gt;K&lt;/em&gt;&lt;sub&gt;i&lt;/sub&gt; values of pyruvate oxime and glyoxylate oxime were 7.6 (± 0.9) × 10&lt;sup&gt;-5&lt;/sup&gt; M and 7.4 (± 1.7) × 10&lt;sup&gt;-5&lt;/sup&gt; M, respectively. 4-Imidazolecarboxylic acid’s inhibition was cooperative, and its binding was competitive with respect to PEP, and uncompetitive with respect to E4P. Its equilibrium dissociation constant was 3.0 (± 0.2) × 10&lt;sup&gt;-3&lt;/sup&gt; M.&lt;/p&gt;","abstract_has_math":false,"creators":["Jiang, Shan"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":"Chemical Biology","school":null,"contributors":[],"advisors":["Berti, Paul","Giuseppe Melacini, Murray Junop"],"committee_chairs":[],"committee_members":[],"year":2011,"date_issued":"2011-10","date_published":"2011-10","updated_at":"2026-11-18T19:37:24Z","subjects":["Asp-containing MurA","pH profile characterization","fosfomycin titration","fragment-based approach","transition state analog design","Biochemistry"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://doi.org/10.71548/18487"],"render_values":[{"text":"https://doi.org/10.71548/18487","href":"https://doi.org/10.71548/18487","code":true}]},{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["opendissertations/5746","6627","2119320"],"render_values":[{"text":"opendissertations/5746","href":null,"code":true},{"text":"6627","href":null,"code":true},{"text":"2119320","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/11375/10718","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"http://hdl.handle.net/11375/10718","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://macsphere.mcmaster.ca/server/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Amacsphere.mcmaster.ca%3A11375%2F10718","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Berti, Paul","Giuseppe Melacini, Murray Junop"]},{"key":"dc:contributor.department","label":"Department","values":["Chemical Biology"]},{"key":"dc:creator","label":"Author","values":["Jiang, Shan"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2014-06-18T16:52:22Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2014-06-18T16:52:22Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2011-07-27"]},{"key":"dc:date.issued","label":"Date","values":["2011-10"]},{"key":"dc:type","label":"Dc Type","values":["thesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Asp-containing MurA","pH profile characterization","fosfomycin titration","fragment-based approach","transition state analog design","Biochemistry"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["opendissertations/5746","6627","2119320"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://hdl.handle.net/11375/10718","https://doi.org/10.71548/18487"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["<p>MurA catalyzes the first committed step of peptidoglycan biosynthesis and it is the target of the antibiotic fosfomycin. Due to a Cys-to-Asp substitution in the active site, MurAs from a number of pathogenic bacteria, including <em>Mycobacterium tuberculosis</em> and <em>Borrelia burgdorferi</em> (Lyme disease), are fosfomycin resistant. His-tagged <em>Borrelia burgdorferi</em> MurA (Bb_MurA) and its D116C mutant have been successfully expressed, purified and characterized. The <em>k</em><sub>cat</sub> value of wild-type Bb_MurA was 0.74 ± 0.01 s<sup>-1</sup>. The D116C mutant’s <em>k</em><sub>cat</sub> decreased by 25-fold and was fosfomycin sensitive. The pH profiles of <em>k</em><sub>cat</sub> for both Bb_MurA and its mutant were characterized. There was little difference in p<em>K</em><sub>a1</sub> values, but the p<em>K</em><sub>a2</sub> value shifted from 7.4 ± 0.2 in wild-type enzyme to a value >11 in the mutant. This demonstrated that the p<em>K</em><sub>a2</sub> of 7.4 was due to D116, and that it must be protonated for activity. Fosfomycin inactivation of Bb_MurA<sub>H6</sub>(D116C) was time-dependent and only proceeded in the presence of UDP-GlcNAc. The dissociation constant, <em>K</em><sub>i</sub>, was 5.7 ± 0.4 µM and rate of covalent modification, <em>k</em><sub>inact</sub>, was 0.021 ± 0.003 s<sup>-1</sup>.</p> <p>DAHP synthase catalyzes the first committed step in the shikimate pathway, and its catalysis has been proposed to proceed through two oxacarbenium ion intermediates. Pyruvate oxime, glyoxylate oxime and 4-imidazolecarboxylic acid have been evaluated as inhibitors of DAHP synthase. In the presence of glycerol 3-phosphate, the fitted <em>K</em><sub>i</sub> values of pyruvate oxime and glyoxylate oxime were 7.6 (± 0.9) × 10<sup>-5</sup> M and 7.4 (± 1.7) × 10<sup>-5</sup> M, respectively. 4-Imidazolecarboxylic acid’s inhibition was cooperative, and its binding was competitive with respect to PEP, and uncompetitive with respect to E4P. Its equilibrium dissociation constant was 3.0 (± 0.2) × 10<sup>-3</sup> M.</p>"]},{"key":"dc:description.degree","label":"Dc Description Degree","values":["Master of Science (MSc)"]},{"key":"dc:title","label":"Title","values":["Characterization of Fosfomycin-Resistant MurA from Borrelia burgdorferi, Fragment-based Inhibitor Design for AroA and DAHP Synthase"]},{"key":"others:access_status","label":"Others Access Status","values":["open.access"]}]}],"canonical_facts":{"dc:contributor.advisor":["Berti, Paul","Giuseppe Melacini, Murray Junop"],"dc:contributor.department":["Chemical Biology"],"dc:creator":["Jiang, Shan"],"dc:date.accessioned":["2014-06-18T16:52:22Z"],"dc:date.available":["2014-06-18T16:52:22Z"],"dc:date.created":["2011-07-27"],"dc:date.issued":["2011-10"],"dc:description.abstract":["<p>MurA catalyzes the first committed step of peptidoglycan biosynthesis and it is the target of the antibiotic fosfomycin. Due to a Cys-to-Asp substitution in the active site, MurAs from a number of pathogenic bacteria, including <em>Mycobacterium tuberculosis</em> and <em>Borrelia burgdorferi</em> (Lyme disease), are fosfomycin resistant. His-tagged <em>Borrelia burgdorferi</em> MurA (Bb_MurA) and its D116C mutant have been successfully expressed, purified and characterized. The <em>k</em><sub>cat</sub> value of wild-type Bb_MurA was 0.74 ± 0.01 s<sup>-1</sup>. The D116C mutant’s <em>k</em><sub>cat</sub> decreased by 25-fold and was fosfomycin sensitive. The pH profiles of <em>k</em><sub>cat</sub> for both Bb_MurA and its mutant were characterized. There was little difference in p<em>K</em><sub>a1</sub> values, but the p<em>K</em><sub>a2</sub> value shifted from 7.4 ± 0.2 in wild-type enzyme to a value >11 in the mutant. This demonstrated that the p<em>K</em><sub>a2</sub> of 7.4 was due to D116, and that it must be protonated for activity. Fosfomycin inactivation of Bb_MurA<sub>H6</sub>(D116C) was time-dependent and only proceeded in the presence of UDP-GlcNAc. The dissociation constant, <em>K</em><sub>i</sub>, was 5.7 ± 0.4 µM and rate of covalent modification, <em>k</em><sub>inact</sub>, was 0.021 ± 0.003 s<sup>-1</sup>.</p> <p>DAHP synthase catalyzes the first committed step in the shikimate pathway, and its catalysis has been proposed to proceed through two oxacarbenium ion intermediates. Pyruvate oxime, glyoxylate oxime and 4-imidazolecarboxylic acid have been evaluated as inhibitors of DAHP synthase. In the presence of glycerol 3-phosphate, the fitted <em>K</em><sub>i</sub> values of pyruvate oxime and glyoxylate oxime were 7.6 (± 0.9) × 10<sup>-5</sup> M and 7.4 (± 1.7) × 10<sup>-5</sup> M, respectively. 4-Imidazolecarboxylic acid’s inhibition was cooperative, and its binding was competitive with respect to PEP, and uncompetitive with respect to E4P. Its equilibrium dissociation constant was 3.0 (± 0.2) × 10<sup>-3</sup> M.</p>"],"dc:description.degree":["Master of Science (MSc)"],"dc:identifier.other":["opendissertations/5746","6627","2119320"],"dc:identifier.uri":["http://hdl.handle.net/11375/10718","https://doi.org/10.71548/18487"],"dc:subject":["Asp-containing MurA","pH profile characterization","fosfomycin titration","fragment-based approach","transition state analog design","Biochemistry"],"dc:title":["Characterization of Fosfomycin-Resistant MurA from Borrelia burgdorferi, Fragment-based Inhibitor Design for AroA and DAHP Synthase"],"dc:type":["thesis"],"others:access_status":["open.access"]},"updated_at":"2026-11-18T19:37:24Z"}